FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1780-1789 October 26, 2006 Number 17 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background The optimal duration of oral anticoagulation in patients with idiopathic venous thromboembolism is uncertain. Testing of D-dimer levels may play a role in the assessment of the need for prolonged anticoagulation.

Methods We performed D-dimer testing 1 month after the discontinuation of anticoagulation in patients with a first unprovoked proximal deep-vein thrombosis or pulmonary embolism who had received a vitamin K antagonist for at least 3 months. Patients with a normal D-dimer level did not resume anticoagulation, whereas those with an abnormal D-dimer level were randomly assigned either to resume or to discontinue treatment. The study outcome was the composite of recurrent venous thromboembolism and major bleeding during an average follow-up of 1.4 years.

Results The D-dimer assay was abnormal in 223 of 608 patients (36.7%). A total of 18 events occurred among the 120 patients who stopped anticoagulation (15.0%), as compared with 3 events among the 103 patients who resumed anticoagulation (2.9%), for an adjusted hazard ratio of 4.26 (95% confidence interval [CI], 1.23 to 14.6; P=0.02). Thromboembolism recurred in 24 of 385 patients with a normal D-dimer level (6.2%). Among patients who stopped anticoagulation, the adjusted hazard ratio for recurrent thromboembolism among those with an abnormal D-dimer level, as compared with those with a normal D-dimer level, was 2.27 (95% CI, 1.15 to 4.46; P=0.02).

Conclusions Patients with an abnormal D-dimer level 1 month after the discontinuation of anticoagulation have a significant incidence of recurrent venous thromboembolism, which is reduced by the resumption of anticoagulation. The optimal course of anticoagulation in patients with a normal D-dimer level has not been clearly established. (ClinicalTrials.gov number, NCT00264277 [ClinicalTrials.gov] .)

Source Information

From the S. Orsola-Malpighi University Hospital, Bologna, (G.P., B.C., C.L., C.B.); S. Bortolo Hospital, Vicenza (A. Tosetto); the University of Perugia, Perugia (A.I.); the University Hospital, Padua (V.P.); Arcispe-dale Santa Maria Nuova, Reggio Emilia (A.G.); General Hospital, Parma (C.P.); General Hospital, Cremona (S.T.); and Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Istituto di Ricovero e Cura a Carattere Scientifico, Maggiore Hospital, Milan (A. Tripodi) — all in Italy; and the Academic Medical Center, Amsterdam (A.W.A.L.).

Address reprint requests to Dr. Palareti at the Department of Angiology and Blood Coagulation, S. Orsola-Malpighi University Hospital, Via Albertoni 15, 40138 Bologna, Italy, or at palareti{at}tin.it.

Full Text of this Article

Related Letters:

D-Dimer and Duration of Anticoagulation
Pernod G., Sevestre M.-A., Labarere J., Mannarino E., Schillaci G., Kevorkian J.-P., Virally M.-L., Bergmann J.-F., Glynn R. J., Goldhaber S. Z., Ridker P. M., Palareti G., Cosmi B., Iorio A.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:421-423, Jan 25, 2007. Correspondence

This article has been cited by other articles:

• Verhovsek, M., Douketis, J. D., Yi, Q., Shrivastava, S., Tait, R. C., Baglin, T., Poli, D., Lim, W. (2008). Systematic Review: D-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism. ANN INTERN MED 149: 481-490 [Abstract] [Full Text]  
• Authors/Task Force Members, , Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galie, N., Pruszczyk, P., Bengel, F., Brady, A. J.B., Ferreira, D., Janssens, U., Klepetko, W., Mayer, E., Remy-Jardin, M., Bassand, J.-P., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Zamorano, J.-L., Andreotti, F., Ascherman, M., Athanassopoulos, G., De Sutter, J., Fitzmaurice, D., Forster, T., Heras, M., Jondeau, G., Kjeldsen, K., Knuuti, J., Lang, I., Lenzen, M., Lopez-Sendon, J., Nihoyannopoulos, P., Perez Isla, L., Schwehr, U., Torraca, L., Vachiery, J.-L. (2008). Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29: 2276-2315 [Full Text]  
• Kearon, C. MB PhD (2008). Stopping anticoagulant therapy after an unprovoked venous thromboembolism. CMAJ 179: 401-402 [Full Text]  
• Rodger, M. A. MD MSc, Kahn, S. R. MD MSc, Wells, P. S. MD MSc, Anderson, D. A. MD, Chagnon, I. MD, Le Gal, G. MD PhD, Solymoss, S. MD, Crowther, M. MD, Perrier, A. MD, White, R. MD, Vickars, L. MD, Ramsay, T. PhD MSc, Betancourt, M. T. MD MSc, Kovacs, M. J. MD (2008). Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179: 417-426 [Abstract] [Full Text]  
• Siragusa, S., Malato, A., Anastasio, R., Cigna, V., Milio, G., Amato, C., Bellisi, M., Attanzio, M. T., Cormaci, O., Pellegrino, M., Dolce, A., Casuccio, A., Bajardi, G., Mariani, G. (2008). Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. Blood 112: 511-515 [Abstract] [Full Text]  
• Legnani, C., Palareti, G., Cosmi, B., Cini, M., Tosetto, A., Tripodi, A., for the PROLONG Investigators (on behalf of FCSA a, (2008). Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. haematol 93: 900-907 [Abstract] [Full Text]  
• Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., Comerota, A. J. (2008). Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 454S-545S [Abstract] [Full Text]  
• Tapson, V. F. (2008). Acute Pulmonary Embolism. NEJM 358: 1037-1052 [Full Text]  
• Heit, J. A. (2008). The Epidemiology of Venous Thromboembolism in the Community. Arterioscler. Thromb. Vasc. Bio. 28: 370-372 [Full Text]  
• Moll, S. (2008). A Clinical Perspective of Venous Thromboembolism. Arterioscler. Thromb. Vasc. Bio. 28: 373-379 [Full Text]  
• Wakefield, T. W., Myers, D. D., Henke, P. K. (2008). Mechanisms of Venous Thrombosis and Resolution. Arterioscler. Thromb. Vasc. Bio. 28: 387-391 [Abstract] [Full Text]  
• Douketis, J. D., Gu, C. S., Schulman, S., Ghirarduzzi, A., Pengo, V., Prandoni, P. (2007). The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism. ANN INTERN MED 147: 766-774 [Abstract] [Full Text]  
• DeLoughery, T. G. (2007). Update in Hematology. ANN INTERN MED 147: 717-724 [Full Text]  
• Silverstein, R. L., Bauer, K. A., Cushman, M., Esmon, C. T., Ershler, W. B., Tracy, R. P. (2007). Venous thrombosis in the elderly: more questions than answers. Blood 110: 3097-3101 [Full Text]  
• Glynn, R. J., Ridker, P. M, Goldhaber, S. Z., Buring, J. E. (2007). Effect of Low-Dose Aspirin on the Occurrence of Venous Thromboembolism: A Randomized Trial. ANN INTERN MED 147: 525-533 [Abstract] [Full Text]  
• Schmitt, B., Baugh, M., Scaglione, S. (2007). Practice corner: Chair's rounds. Evid. Based Med. 12: 133-134 [Full Text]  
• Laczkovics, C., Grafenhofer, H., Kaider, A., Quehenberger, P., Simanek, R., Mannhalter, C., Lechner, K., Pabinger, I. (2007). Risk of recurrence after a first venous thromboembolic event in young women. haematol 92: 1201-1207 [Abstract] [Full Text]  
• Harrington, D. W., Munekata, M. T. (2007). Update in General Internal Medicine. ANN INTERN MED 147: 104-116 [Full Text]  
• Lord, S. J., Irwig, L., Simes, R. J. (2007). A Philosophical Approach to Diagnostic Test Evaluation. ANN INTERN MED 146: 757-758 [Full Text]  
• Crowther, M. (2007). An abnormal D-dimer test result indicated that anticoagulant therapy should be continued. Evid. Based Med. 12: 45-45 [Full Text]  
• Lindsay, A. (2007). JournalScan. Heart 93: 277-278 [Full Text]  
• Pernod, G., Sevestre, M.-A., Labarere, J., Mannarino, E., Schillaci, G., Kevorkian, J.-P., Virally, M.-L., Bergmann, J.-F., Glynn, R. J., Goldhaber, S. Z., Ridker, P. M., Palareti, G., Cosmi, B., Iorio, A. (2007). D-Dimer and Duration of Anticoagulation. NEJM 356: 421-423 [Full Text]  
• Heit, J. A. (2007). Thrombophilia: Common Questions on Laboratory Assessment and Management. ASH Education Book 2007: 127-135 [Abstract] [Full Text]  
• Tonks, A. (2006). What's new in the other general journals. BMJ 333: 963-964 [Full Text]  
• (2006). D-Dimer to Determine Duration of Anticoagulation After Venous Thromboembolism. JWatch General 2006: 1-1 [Full Text]  
• (2006). Duration of Oral Anticoagulation for Venous Thromboembolism. JWatch Oncology and Hematology 2006: 1-1 [Full Text]  
• (2006). Should D-Dimer Testing Guide the Duration of Anticoagulation After Unprovoked VTE?. Journal Watch Cardiology 2006: 4-4 [Full Text]